Tag: TWN ASA NYK UNE USA NAM

Advantech Unveils Next-Generation Edge AI Compute Solutions Powered by Qualcomm Snapdragon X Elite

TAIPEI, July 7, 2025 /PRNewswire/ -- Advantech is proud to introduce its latest suite of high-performance edge AI compute solutions powered by the Snapdragon®...

Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer’s Disease

TAINAN, June 12, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsTWN ASA NYK UNE USA NAM

Allergy/Immunology Leaders Unite to Strengthen the Specialty Workforce and Expand Access to High Quality Care

Global Jewelry Market Size to Reach USD 659 Billion by 2035, Growing at 5.6% CAGR | Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

FlowTex Energy Reports Record Well Performance, Secures Six New Wells, and Expands into Aviation and Real Estate

Tag: TWN ASA NYK UNE USA NAM

Advantech Unveils Next-Generation Edge AI Compute Solutions Powered by Qualcomm Snapdragon X Elite

Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer’s Disease

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us